Uploaded on Jan 21, 2022
This work describes formulation of solid lipid nanoparticle (SLN) of piperine to exploit its efficacy orally and topically. Piperine SLN formulations prepared by melt emulsification method were optimized by the application of 32 factorial design. The nanoparticulate dispersion was evaluated for particle size, entrapment efficiency and zeta potential (ZP).
Research paper description Dr. MRB May 2021
Research paper of Dr. Mangesh Bhalekar for the month of May 2021
Title: Formulation of piperine solid lipid nanoparticles (SLN) for treatment of
rheumatoid arthritis.
Authors: Mangesh R. Bhalekar, Ashwini R. Madgulkar, Puja S. Desale and Gyce Marium
Journal Details: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, (2017), 43:6,
1003-1010,.
Publisher: Taylor & Francis.
Description: This work describes formulation of solid lipid nanoparticle (SLN) of piperine to
exploit its efficacy orally and topically. Piperine SLN formulations prepared by melt
emulsification method were optimized by the application of 32 factorial design.
The nanoparticulate dispersion was evaluated for particle size, entrapment efficiency and zeta
potential (ZP).
The optimized batch had average size of 128.80 nm, entrapment efficiency of 78.71% and zeta
potential 23.34 mV). Further characterization was done by differential scanning calorimetry
(DSC), X-ray diffraction which revealed piperine was present in SLN as amorphous form.
The SLN were administered orally and topically to CFA-induced arthritic rats. Ex vivo study
using Franz diffusion cell indicate that piperine from SLN gel formulation accumulates in the
skin. Pharmacodynamic study result indicates both the topical and oral piperine evoked a
significant response as compared to orally administered chloroquine suspension. The results of
ELISA show significant reduction in TNFa in treated rat which mightbe the reason behind the
DMARD action of piperine SLN.
Photographs:
Comments